logo-loader

Full interview: CEO Rodney Varner sees newly licensed therapy as an 'opportunity we couldn't pass up'

Published: 13:27 14 Feb 2020 EST

 (NASDAQ:GNPX) CEO Rodney Varner tells Proactive the Texas-based biotech has signed a licensing agreement with the University of Pittsburgh for a therapy that could have the potential to treat Type 1 and Type 2 diabetes.

Varner says the newly licensed therapy was an 'opportunity we couldn't pass up' because of its large market opportunity and 'massive' medical need.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

17 minutes ago